TRACON Pharmaceuticals Inc.

(NASDAQ:TCON) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies.

Contact Information

Website: www.traconpharma.com
Email: mwiggins@traconpharma.com
Main Phone: +1 858 550-0780
Address: 4350 La Jolla Village Drive
Address 2: Suite 800
State: CA
City / Town: San Diego
Country: US
Postal Code: 92122

Issuer Information

Exchange: NSC
CEO: Charles P. Theuer
Employees: 18
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A